What is Trigger Finger?

Trigger Finger (stenosing tenosynovitis) is a condition in which the flexor tendon thickens and cannot glide freely through the A1 pulley. The finger "locks" in a flexed position and extends with a characteristic click or does not extend at all.

The condition affects 2-3% of the population, more commonly women aged 40-60. In diabetes, the risk increases to 10%. It may affect multiple fingers simultaneously.

Stages (Quinnell classification):

  • I — pain, nodule, without locking
  • II — click during movement, finger extends independently
  • III — locking, finger extends only passively (with the other hand)
  • IV — fixed flexion contracture

Symptoms:

  • Clicking during finger extension
  • Locking in flexed position
  • Painful nodule at the base of the finger on the palm
  • Morning stiffness, worsening after rest
  • Pain when gripping objects

Facts

  • ICD-10: M65.3
  • Prevalence: 2-3% of population
  • In diabetes: up to 10%
  • Gender: women 2-6 times more often
  • Most common: ring finger and thumb

How MIBRAR® treats Trigger Finger

01

Ultrasound Diagnosis

Sono Control Arm™ visualizes the thickened tendon, A1 pulley, and nodule presence — dynamically during finger flexion-extension.

02

Obtaining Concentrates

CGF — anti-inflammatory factors to reduce tendon swelling. Lipogems® — stem cells for regeneration and normalization of gliding.

03

Injection into Tendon Sheath

Under ultrasound guidance, concentrates are injected into the tendon sheath under the A1 pulley — precisely into the impingement zone. Multiple fingers are treated in one procedure.

04

Restoration of Gliding

Anti-inflammatory factors reduce tendon swelling, stem cells restore normal structure. The finger flexes and extends freely again without clicking.

MIBRAR® Method Advantages

95% of interventions covered

MIBRAR® covers up to 95% of all spinal neurosurgery and orthopedic operations.

No anesthesia or incisions

Outpatient treatment via 0.3-1.5 mm puncture. No general anesthesia or hospitalization.

No age restrictions

Regeneration at any age. Safe for chronic conditions and anesthesia intolerance.

Rapid improvement

Concentrates have analgesic and anti-inflammatory properties. Relief within days.

Multiple zones at once

Simultaneous treatment of multiple discs or joints in one procedure.

Home the same day

No crutches, braces or rehabilitation needed. MRI follow-up at 8-16 weeks.

MIBRAR® Technology

Cyber Navi Hand™ — MIBRAR® navigation system

Cyber Navi Hand™

Intraoperative robotic navigation system. Provides precise access to deep structures with 1 mm and 1 degree accuracy.

Sono Control Arm™ — MIBRAR® ultrasound control

Sono Control Arm™

Device for intervention under sonographic control. Eliminates open surgeries with real-time visual monitoring.

Video about the MIBRAR® Method

Frequently Asked Questions about Treatment of Trigger Finger

Why preserve the A1 pulley?
The A1 pulley is the first annular pulley that holds the tendon against the bone. Its incision during surgery can lead to the "bowstringing" phenomenon — the tendon pulls away from the bone, reducing flexion strength. MIBRAR® resolves the issue biologically, preserving all anatomical structures.
Can multiple fingers be treated at once?
Yes. MIBRAR® allows treatment of all affected fingers on both hands in a single procedure. This is particularly important in diabetes, when multiple fingers are often affected. In surgery, each finger is operated on separately.
How quickly will the clicking resolve?
Reduction in clicking occurs within 1-2 weeks as tendon swelling subsides. Complete resolution occurs within 3-6 weeks. In early stages (I-II), results are faster. In stage IV (contracture), combination with physical therapy may be required.

Ready to get rid of pain?

Get a consultation for your case

Book a Consultation